View profile

Letter #53 - Coronavirus Tests To Get Cheaper In Delhi, Capped At Rs 2,400 / Dexamethasone proves first life-saving drug

Today's topics: Outbreak in India - Outbreak globally - Economic impact - Steroid dexamethasone appro
Letters About COVID19
Letter #53 - Coronavirus Tests To Get Cheaper In Delhi, Capped At Rs 2,400 / Dexamethasone proves first life-saving drug
By @salmanmushir • Issue #53 • View online
Today’s topics: Outbreak in India - Outbreak globally - Economic impact - Steroid dexamethasone approved for use in COVID-19 treatment in U.K - Treatment updates in India - IITs innovate to beat Covid crisis - Politics of COVID-19 - Other recommendations

Outbreak in India
India actual and predicted new daily cases
Coronavirus in India and Brazil: new forecasts for when economic giants will hit peak
Outbreak globally
Economic impact
Steroid dexamethasone approved for use in COVID-19 treatment in U.K
Dexamethasone is a cheap and globally available drug that can help save the lives of people seriously ill with coronavirus. It’s a major breakthrough in the fight against the deadly virus, according to UK scientists. “There is a clear, clear benefit. The treatment is up to 10 days of dexamethasone and it costs about £5 per patient. So essentially it costs £35 to save a life,” Prof Martin Landray of Oxford University said. The low-dose steroid treatment is part of the world’s biggest study into existing treatments, and cuts the risk of death by a third for patients on ventilators. - BBC News
Livemint
For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO

https://t.co/thq2XV8pRv
Dexamethasone, the steroid helping save Covid lives
Dexamethasone, the steroid helping save Covid lives
Treatment updates in India
IITs innovate to beat Covid crisis
Several innovations by the IITs are ready to hit the market in the fight against Covid-19. India’s premier engineering institutes have either licensed these solutions to companies while retaining the patent rights, or have taken the commercial route through IIT-incubated startups
Politics of COVID-19
The New York Times
For-profit online colleges are taking advantage of the coronavirus pandemic to market themselves to potential students. But the industry has a troubled history, with many students failing to graduate while incurring mounds of debt. https://t.co/xn0XzUDRpy
Miscellaneous recommendations
This newsletter is created by - @salmanmushir, from Bangalore, India. I host a podcast called Salman Needs A Job, and I create content about jobs on my Instagram and YouTube. Other projects: lifepro.tools21 days later.
Next one on Monday.
Did you enjoy this issue?
@salmanmushir

India focussed newsletter navigating the COVID-19 situation, delivered Mondays & Thursdays (previously daily).

If you don't want these updates anymore, please unsubscribe here.
If you were forwarded this newsletter and you like it, you can subscribe here.
Powered by Revue
Washing hands quite frequently in Bangalore.